Beta Bionics (BBNX) Research & Development (2024 - 2026)

Beta Bionics has disclosed Research & Development across 3 years of filings, most recently posting $10.4 million for Q1 2026.

• Research & Development for Q1 2026 came in at $10.4 million, up 36.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $37.6 million (up 32.73% YoY), and the FY2025 annual result was $34.8 million, up 32.86% from the prior year.
• Research & Development came in at $10.4 million for Q1 2026 at Beta Bionics, up from $10.1 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $10.4 million in Q1 2026 to a low of $5.1 million in Q3 2024.
• The 3-year median for Research & Development is $8.2 million (2025), against an average of $7.9 million.
• Peak annual rise in Research & Development reached 59.4% in 2025, while the deepest fall reached 9.95% in 2025.
• Beta Bionics' Research & Development stood at $9.2 million in 2024, then increased by 9.95% to $10.1 million in 2025, then increased by 2.22% to $10.4 million in 2026.
• The last three Research & Development figures came in at $10.4 million (Q1 2026), $10.1 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.